CN100558367C - 化合物在制备用于提高癌症治疗疗效的药物中的用途 - Google Patents
化合物在制备用于提高癌症治疗疗效的药物中的用途 Download PDFInfo
- Publication number
- CN100558367C CN100558367C CNB028160037A CN02816003A CN100558367C CN 100558367 C CN100558367 C CN 100558367C CN B028160037 A CNB028160037 A CN B028160037A CN 02816003 A CN02816003 A CN 02816003A CN 100558367 C CN100558367 C CN 100558367C
- Authority
- CN
- China
- Prior art keywords
- purposes
- galectins
- chemical compound
- cell
- pectin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/732—Pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Description
Claims (15)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29999101P | 2001-06-21 | 2001-06-21 | |
US60/299,991 | 2001-06-21 | ||
US10/176,235 | 2002-06-20 | ||
US10/176,235 US6680306B2 (en) | 2001-06-21 | 2002-06-20 | Method for enhancing the effectiveness of cancer therapies |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1543351A CN1543351A (zh) | 2004-11-03 |
CN100558367C true CN100558367C (zh) | 2009-11-11 |
Family
ID=26872020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB028160037A Expired - Fee Related CN100558367C (zh) | 2001-06-21 | 2002-06-21 | 化合物在制备用于提高癌症治疗疗效的药物中的用途 |
Country Status (11)
Country | Link |
---|---|
US (3) | US6680306B2 (zh) |
EP (1) | EP1406639A4 (zh) |
JP (1) | JP2004535430A (zh) |
CN (1) | CN100558367C (zh) |
AU (1) | AU2002320140B2 (zh) |
BR (1) | BR0210550A (zh) |
CA (1) | CA2451841A1 (zh) |
CZ (1) | CZ200487A3 (zh) |
IL (1) | IL159461A0 (zh) |
MX (1) | MXPA03012021A (zh) |
WO (1) | WO2003000118A2 (zh) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7312237B2 (en) * | 2001-03-14 | 2007-12-25 | Bristol-Myers Squibb Co. | Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolilferative diseases |
US6680306B2 (en) * | 2001-06-21 | 2004-01-20 | Glycogenesys, Inc. | Method for enhancing the effectiveness of cancer therapies |
US20030004132A1 (en) * | 2001-06-22 | 2003-01-02 | Yan Chang | Method and material for treating immune diseases |
US6890906B2 (en) | 2001-11-21 | 2005-05-10 | Glycogenesys, Inc. | Method for controlling angiogenesis in animals |
US20040121981A1 (en) * | 2001-11-21 | 2004-06-24 | Glycogenesys, Inc. | Method for controlling angiogenesis in animals |
US20040259816A1 (en) * | 2002-10-01 | 2004-12-23 | Pandol Stephen J. | Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof |
EP1980257A1 (en) | 2003-04-07 | 2008-10-15 | Prospect Therapeutics, Inc. | Compositions and uses of galectin antagonists |
US20040223971A1 (en) * | 2003-04-07 | 2004-11-11 | Glycogenesys, Inc. | Composition and uses of galectin antagonists |
CN1838942A (zh) * | 2003-07-11 | 2006-09-27 | 普罗医药公司 | 递送疏水性药物的组合物和方法 |
DE10335236B3 (de) * | 2003-08-01 | 2005-02-24 | Drägerwerk AG | Messsystem für die Bestimmung der Konzentration von Propofol (2,6-Diisopropylphenol) im Atemstrom |
US20050053664A1 (en) | 2003-09-08 | 2005-03-10 | Eliezer Zomer | Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer |
EP2591786B1 (en) | 2003-10-16 | 2017-04-12 | Cancure Limited | Immunomodulating compositions and uses therefor |
US20050282773A1 (en) * | 2004-01-14 | 2005-12-22 | Pro-Pharmaceuticals, Inc. | Modified polysaccharides in combination with anti-cancer drugs for enhanced treatment of cancer |
WO2005079314A2 (en) * | 2004-02-13 | 2005-09-01 | Pro-Pharmaceuticals, Inc. | Compositions and methods used to treat acne and candida |
US8128966B2 (en) | 2004-03-26 | 2012-03-06 | La Jolla Pharmaceutical Company | Modified pectins, compositions and methods related thereto |
WO2006020027A1 (en) * | 2004-07-14 | 2006-02-23 | Glycogenesys, Inc. | Composition and method for treating hyperproliferative diseases |
WO2006017417A2 (en) * | 2004-08-02 | 2006-02-16 | Pro-Pharmaceuticals, Inc. | Compositions and methods for the enhancement of chemotherapy with microbial cytotoxins |
AU2006227880A1 (en) * | 2005-03-23 | 2006-09-28 | Pfizer Products Inc. | Anti-CTLA4 antibody and indolinone combination therapy for treatment of cancer |
US8221803B1 (en) | 2007-06-25 | 2012-07-17 | OncoNatural Solutions, Inc. | Composition for prostate health |
EP2184997A4 (en) * | 2007-07-31 | 2010-11-03 | Univ New York | DIAGNOSIS AND TREATMENT METHODS FOR THE CHARACTERIZATION OF BACTERIAL MICROORGANISMS IN SKIN DISEASES |
CA2778953C (en) | 2009-11-13 | 2020-01-14 | Dana-Farber Cancer Institute, Inc. | Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1 |
RU2545859C1 (ru) * | 2011-12-08 | 2015-04-10 | Исаак ЭЛИАС | Уменьшение уровней галектина-3 посредством плазмафереза |
BR112014015940B1 (pt) | 2011-12-28 | 2022-08-09 | Galectin Therapeutics, Inc | Polissacarídeo de grau farmacêutico, composição, e seus usos |
WO2013152313A1 (en) * | 2012-04-05 | 2013-10-10 | The Regents Of The University Of California | Compositions and methods for treating cancer and diseases and conditions responsive to growth factor inhibition |
BR112014030534A2 (pt) | 2012-06-06 | 2017-06-27 | Galectin Therapeutics Inc | composições de galacto-ramnogalacturonato para o tratamento de doenças associadas com óxido nítrico sintase induzível elevada |
WO2014043708A1 (en) | 2012-09-17 | 2014-03-20 | Traber Peter G | Method for enhancing specific immunotherapies in cancer treatment |
US8828971B2 (en) | 2012-10-10 | 2014-09-09 | Galectin Therapeutics, Inc. | Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders |
WO2014130648A1 (en) | 2013-02-20 | 2014-08-28 | Galectin Therapeutics, Inc. | Method for treatment of pulmonary fibrosis |
CA2930817A1 (en) | 2013-11-17 | 2015-05-21 | Rdd Pharma Ltd. | Methods for treating radiation induced gastrointestinal tract injury |
JP7032406B2 (ja) | 2016-09-13 | 2022-03-08 | ラスナ・リサーチ・インコーポレイテッド | ダクチノマイシン組成物並びに骨髄異形成症候群及び急性骨髄性白血病の治療方法 |
US11576924B2 (en) | 2017-05-12 | 2023-02-14 | Galectin Sciences, Llc | Compounds for the prevention and treatment of diseases and the use thereof |
US11633399B2 (en) | 2018-12-25 | 2023-04-25 | Sol-Gel Technologies Ltd. | Treatment of skin disorders with compositions comprising an EGFR inhibitor |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US107222A (en) * | 1870-09-13 | Improvement in machines for tenoning window-sash | ||
US5490991A (en) | 1986-07-03 | 1996-02-13 | Advanced Magnetics, Inc. | Directed delivery of radioprotectants using a receptor specific carrier |
US5843442A (en) | 1990-10-22 | 1998-12-01 | Corvas International, Inc. | Blood coagulation protein antagonists and uses therefor |
US5639737A (en) | 1991-11-04 | 1997-06-17 | Co Enzyme Technology Ltd. | Method and compositions for treating malignant tumors and inhibiting growth and metastases of malignant tumors |
US20020107222A1 (en) | 1993-03-01 | 2002-08-08 | David Platt | Modified polysaccharides for treatment of cancer |
US5490911A (en) * | 1993-11-26 | 1996-02-13 | The United States Of America As Represented By The Department Of Energy | Reactive multilayer synthesis of hard ceramic foils and films |
US5498702A (en) * | 1993-12-16 | 1996-03-12 | California Natural Products | Treated pectinic acid process and product |
US5834442A (en) | 1994-07-07 | 1998-11-10 | Barbara Ann Karmanos Cancer Institute | Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin |
US5681923A (en) | 1995-10-06 | 1997-10-28 | Platt; David | Tumor derived carbohydrate binding protein |
EP0888776A4 (en) * | 1996-03-15 | 2005-01-26 | Takara Bio Inc | PRODUCT OBTAINED BY THERMAL TREATMENT OF URONIC ACID, AND FOOD, BEVERAGES OR MEDICAMENTS CONTAINING THE SAME |
US5831052A (en) * | 1997-05-07 | 1998-11-03 | Incyte Pharmaceuticals, Inc. | New human translocation associated protein |
AU751932B2 (en) * | 1997-10-15 | 2002-08-29 | Polarx Biopharmaceuticals, Inc. | Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
CA2279791C (en) * | 1998-08-14 | 2011-11-08 | Marcus B. Gohlke | Dietary supplement combining colostrum and lactorferrin in a mucosal delivery format |
US6500807B1 (en) * | 1999-02-02 | 2002-12-31 | Safescience, Inc. | Modified pectin and nucleic acid composition |
US6274566B1 (en) * | 1999-02-23 | 2001-08-14 | Econugenics, Inc. | Methods for treating mammals with modified alginates and pectins |
US6642205B2 (en) * | 2000-09-25 | 2003-11-04 | Pro-Pharmaceuticals, Inc. | Methods and compositions for reducing side effects in chemotherapeutic treatments |
US20020104222A1 (en) * | 2001-02-06 | 2002-08-08 | Jay Larry Dean | Knife for removing the hide of an animal and method therefor |
US6914055B2 (en) * | 2001-03-27 | 2005-07-05 | Anatole Klyosov | Delivery of a therapeutic agent in a formulation for reduced toxicity |
US6982255B2 (en) * | 2001-03-27 | 2006-01-03 | Anatole Klyosov | Delivery of a therapeutic agent in a formulation for reduced toxicity |
US6645946B1 (en) * | 2001-03-27 | 2003-11-11 | Pro-Pharmaceuticals, Inc. | Delivery of a therapeutic agent in a formulation for reduced toxicity |
US7012068B2 (en) * | 2001-03-27 | 2006-03-14 | Pro-Pharmaceuticals, Inc. | Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer |
US6680306B2 (en) * | 2001-06-21 | 2004-01-20 | Glycogenesys, Inc. | Method for enhancing the effectiveness of cancer therapies |
US20040223971A1 (en) * | 2003-04-07 | 2004-11-11 | Glycogenesys, Inc. | Composition and uses of galectin antagonists |
WO2006020027A1 (en) * | 2004-07-14 | 2006-02-23 | Glycogenesys, Inc. | Composition and method for treating hyperproliferative diseases |
-
2002
- 2002-06-20 US US10/176,235 patent/US6680306B2/en not_active Expired - Fee Related
- 2002-06-21 MX MXPA03012021A patent/MXPA03012021A/es not_active Application Discontinuation
- 2002-06-21 WO PCT/US2002/019885 patent/WO2003000118A2/en active Application Filing
- 2002-06-21 JP JP2003506572A patent/JP2004535430A/ja active Pending
- 2002-06-21 AU AU2002320140A patent/AU2002320140B2/en not_active Ceased
- 2002-06-21 CA CA002451841A patent/CA2451841A1/en not_active Abandoned
- 2002-06-21 IL IL15946102A patent/IL159461A0/xx unknown
- 2002-06-21 CZ CZ200487A patent/CZ200487A3/cs unknown
- 2002-06-21 EP EP02749641A patent/EP1406639A4/en not_active Withdrawn
- 2002-06-21 BR BR0210550-0A patent/BR0210550A/pt not_active IP Right Cessation
- 2002-06-21 CN CNB028160037A patent/CN100558367C/zh not_active Expired - Fee Related
-
2003
- 2003-04-07 US US10/408,723 patent/US20040023925A1/en not_active Abandoned
- 2003-09-08 US US10/657,383 patent/US20040043962A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20030013681A1 (en) | 2003-01-16 |
US20040043962A1 (en) | 2004-03-04 |
WO2003000118A2 (en) | 2003-01-03 |
JP2004535430A (ja) | 2004-11-25 |
CN1543351A (zh) | 2004-11-03 |
CZ200487A3 (cs) | 2004-10-13 |
BR0210550A (pt) | 2004-05-25 |
WO2003000118A3 (en) | 2003-04-10 |
EP1406639A2 (en) | 2004-04-14 |
US6680306B2 (en) | 2004-01-20 |
CA2451841A1 (en) | 2003-01-03 |
AU2002320140B2 (en) | 2007-11-29 |
US20040023925A1 (en) | 2004-02-05 |
MXPA03012021A (es) | 2004-06-03 |
IL159461A0 (en) | 2004-06-01 |
EP1406639A4 (en) | 2004-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100558367C (zh) | 化合物在制备用于提高癌症治疗疗效的药物中的用途 | |
AU2002320140A1 (en) | Method for enhancing the effectiveness of cancer therapies | |
CN1096867C (zh) | 抗溃疡剂和幽门螺旋菌粘连抑制剂 | |
JPS6117A (ja) | ムコ多糖系癌転移抑制剤 | |
KR101145248B1 (ko) | 신생혈관형성 억제용 한약 조성물 | |
US6420348B1 (en) | Pectic polysaccharides purified from Angelica gigas nakai and purification method and use as immunostimulating agent thereof | |
CN101322700B (zh) | 柚皮素和柚皮苷作为转化生长因子-β1信号通路抑制剂在制备药物中的应用 | |
CN103976976A (zh) | 一种包载重组人生长激素缓释药物微囊的制法 | |
KR102187681B1 (ko) | 히알루론산 나노입자를 함유하는 섬유증의 예방 또는 치료용 약학 조성물 | |
CN102372770B (zh) | 一种抑血管生成素、纯化方法及含有它们的药物组合物 | |
KR20140050605A (ko) | 간암의 재발, 악화 또는 전이 억제용 의약조성물 | |
CN101933897A (zh) | 注射用重组人血管内皮抑制素温度敏感性凝胶组合物 | |
BR112019002686B1 (pt) | Polissacarídeo tendo ação imuno estimulatória natural e imuno estimulante natural, ou alimento ou bebida compreendendo a mesma | |
JP2006347883A (ja) | 糖鎖含有キトサン誘導体及びグリコサミノグリカンを含有する医療用組成物 | |
CN1838942A (zh) | 递送疏水性药物的组合物和方法 | |
CN101224297A (zh) | 重组人血管内皮抑制素在制药中的应用 | |
CN113842466B (zh) | 一种分子包裹萘莫司他及其在治疗三阴性乳腺癌中的应用 | |
CN114288410B (zh) | Src抑制剂和fak抑制剂在制备用于抑制肺癌转移的药物中的应用 | |
CN106975073A (zh) | 防治奶牛乳房炎的生物材料制剂及其制备方法 | |
CN101068556B (zh) | 富含胰岛素样生长因子的鹿茸纳米化制品及其制备方法 | |
CN101537008A (zh) | 一种家畜使用的头孢喹肟白芨胶生物粘附缓释胶囊 | |
CN117003901A (zh) | 一种改善内皮细胞高糖损伤的金乌贼墨多糖及其制备方法和应用 | |
CN112121043A (zh) | 双香豆素在抗肿瘤中的应用 | |
US20200323784A1 (en) | Use of cxcl12 to promote survival, function, and immunoisolation of stem cell-derived beta cells | |
KR20240086944A (ko) | 연골 재생용 펩타이드 및 이의 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: MARBOROUGH RESEARCH CO., LTD. Free format text: FORMER OWNER: GRIECO GENE SYSTEMS, INC. Effective date: 20080912 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20080912 Address after: Massachusetts Applicant after: Mar Polo research Address before: Massachusetts Applicant before: Glycogenesys Inc. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091111 Termination date: 20100621 |